Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Kollmeier
    Kollmeier
  2. Zhang
    Zhang
  3. Yamada
    Yamada
  4. McBride
    McBride
  5. Brennan
    Brennan
  6. Chou
    Chou
  7. Gorovets
    Gorovets
  8. Romesser
    Romesser
  9. Zaider
    Zaider
  10. Damato
    Damato

Groups

  1. Biostatistics Service (10)
  2. Epidemiology and Biostatistics (10)
  3. GDMT, Radiation Oncology (10)
  4. Gynecology Disease Management Team (10)
  5. Radiation Oncology, Department of (10)
  6. Survivorship Research (10)
  7. Sloan Kettering Institute Postdocs (7)
  8. Medical Physics (3)
  9. Radiotherapy Physics Service (3)
  10. GSK Faculty (1)
Search Within
  1. "Epidemiology and Biostatistics"
  2. "Radiation Oncology, Department of"
  3. "Marisa Kollmeier"
Formats
  1. Journal Article (10)
Groups
  1. Biostatistics Service (10)
  2. Epidemiology and Biostatistics (10)
  3. GDMT, Radiation Oncology (10)
  4. Gynecology Disease Management Team (10)
  5. Radiation Oncology, Department of (10)
  6. Survivorship Research (10)

More Groups

People
  1. Marisa Kollmeier (10)
  2. Michael Zelefsky (10)
  3. Zhigang Zhang (10)
  4. Xin Pei (7)
  5. Yoshiya Yamada (6)
  6. Sean McBride (5)

More People

Years
  1. 2022 (2)
  2. 2019 (1)
  3. 2016 (1)
  4. 2015 (2)
  5. 2013 (1)
  6. 2012 (1)

More Years

Publications
  1. European Urology (3)
  2. Urology (3)
  3. Brachytherapy (2)
  4. Journal of Urology (2)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Failure patterns by PSMA PET for recurrent prostate cancer after prostatectomy and salvage radiation
    Journal Article

    Imber, B. S.; O'Dwyer, E.; Lobaugh, S.; McBride, S. M.; Hopkins, M.; Kollmeier, M.; Gorovets, D.; Brennan, V.; Pike, L. R. G.; Gewanter, R.; more...
    Urology (2022)

    Fulltext@MSK | Save
  • Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost
    Journal Article

    Kollmeier, M. A.; Gorovets, D.; Flynn, J.; McBride, S.; Brennan, V.; Beaudry, J.; Cohen, G.; Damato, A.; Zhang, Z.; Zelefsky, M. J.
    Brachytherapy (2022)

    Fulltext@MSK | Save
  • Long-term implications of a positive posttreatment biopsy in patients treated with external beam radiotherapy for clinically localized prostate cancer
    Journal Article

    Zelefsky, M. J.; Goldman, D. A.; Reuter, V.; Kollmeier, M.; McBride, S.; Zhang, Z.; Varghese, M.; Pei, X.; Fuks, Z.
    Journal of Urology (2019)

    Fulltext@MSK | Save
  • Long-term impact of androgen-deprivation therapy on cardiovascular morbidity after radiotherapy for clinically localized prostate cancer
    Journal Article

    Kohutek, Z. A.; Weg, E. S.; Pei, X.; Shi, W.; Zhang, Z.; Kollmeier, M. A.; Zelefsky, M. J.
    Urology (2016)

    Fulltext@MSK | Save
  • Anatomical patterns of recurrence following biochemical relapse in the dose escalation era of external beam radiotherapy for prostate cancer
    Journal Article

    Zumsteg, Z. S.; Spratt, D. E.; Romesser, P. B.; Pei, X.; Zhang, Z.; Kollmeier, M.; McBride, S.; Yamada, Y.; Zelefsky, M. J.
    Journal of Urology (2015)

    Fulltext@MSK | Save
  • The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy
    Journal Article

    Zumsteg, Z. S.; Spratt, D. E.; Romesser, P. B.; Pei, X.; Zhang, Z. G.; Polkinghorn, W.; McBride, S.; Kollmeier, M.; Yamada, Y.; Zelefsky, M. J.
    European Urology (2015)

    Fulltext@MSK | Save
  • A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy
    Journal Article

    Zumsteg, Z. S.; Spratt, D. E.; Pei, I.; Zhang, Z.; Yamada, Y.; Kollmeier, M.; Zelefsky, M. J.
    European Urology (2013)

    Fulltext@MSK | Save
  • Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experience
    Journal Article

    Zelefsky, M. J.; Chou, J. F.; Pei, X.; Yamada, Y.; Kollmeier, M.; Cox, B.; Zhang, Z.; Schechter, M.; Cohen, G. N.; Zaider, M.
    Brachytherapy (2012)

    Fulltext@MSK | Save
  • Dose escalation for prostate cancer radiotherapy: Predictors of long-term biochemical tumor control and distant metastases-free survival outcomes
    Journal Article

    Zelefsky, M. J.; Pei, X.; Chou, J. F.; Schechter, M.; Kollmeier, M.; Cox, B.; Yamada, Y.; Fidaleo, A.; Sperling, D.; Happersett, L.; more...
    European Urology (2011)

    Fulltext@MSK | Save
  • Real-time intraoperative computed tomography assessment of quality of permanent interstitial seed implantation for prostate cancer
    Journal Article

    Zelefsky, M. J.; Worman, M.; Cohen, G. N.; Pei, X.; Kollmeier, M.; Yamada, J.; Cox, B.; Zhang, Z.; Bieniek, E.; Dauer, L.; more...
    Urology (2010)

    Fulltext@MSK | Save